["Double boosting" passes the test. LPV/r plus SQV in complicated salvage situation].
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D024921:Drug Resistance, Multiple, Viral / Q000187:drug effects*; D004357:Drug Synergism; D005858:Germany; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000008:administration & dosage* / Q000009:adverse effects; D019438:Ritonavir / Q000008:administration & dosage* / Q000009:adverse effects; D016879:Salvage Therapy; D019258:Saquinavir / Q000008:administration & dosage* / Q000009:adverse effects
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019258:Saquinavir; D019438:Ritonavir